Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

TDACW

Translational Development Acquisition Corp.

CIK 0001926599 · Nasdaq

NasdaqFinancialsBlank Checks
$1.90
↓ 0.10 (-5.00%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Technicals; Risks: Fundamentals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$0.00
P/E Ratio
0.00
EPS
Not covered
Dividend Yield
Not covered
52W Position
66%
Beta
2.46

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.00
P/S
Not covered
EV/Revenue
Not covered
ROE
-91.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

117 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 66%
$0.17$2.80

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
$6.36M
Total Assets
$181.70M
Free Cash Flow
–

Recent news